May 23rd, 2025: 9 am AEST
Register here
Are our exercise oncology guidelines fit for purpose: Learnings from an exercise trial involving women with recurrent ovarian cancer
The ECHO-R trial was a phase II trial designed to evaluate the safety and feasibility of adding exercise to chemotherapy for recurrent ovarian cancer. Weekly exercise targets were aligned with international exercise oncology guidelines and women were supported to achieve these targets through 12 exercise counselling telephone calls with study-trained Exercise Oncology Professionals provided over a 6-month period. Quantitative findings on safety, feasibility and effect, and qualitative findings on barriers, attitudes, facilitators and preferences of physical activity will be presented and provide a backdrop for discussing the extent to which our exercise oncology guidelines are fit-for-purpose across our heterogenous cancer population